Quantification and Characterization of Opioid Prescription, Overdose, and Fatalities in People with Cancer: A Massive Nationwide, Multi-Cohort Study
癌症患者阿片类药物处方、用药过量和死亡的量化和表征:一项大规模的全国性多队列研究
基本信息
- 批准号:10372162
- 负责人:
- 金额:$ 7.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAdverse eventAffectAmericanAnalgesicsAreaBenefits and RisksBig Data MethodsBuprenorphineCancer Pain ManagementCancer PatientCancer SurvivorCase Fatality RatesCenters for Disease Control and Prevention (U.S.)ChronicCohort StudiesDataDatabasesDecision MakingDependenceDiagnosisDoseDrug abuseDrug usageEmergency department visitEnrollmentEvaluationEventFloridaFutureGrantGuidelinesHealthcare SystemsHospitalizationHospitalsIncidenceInsuranceKnowledgeLawsLongitudinal cohortMalignant NeoplasmsMatched Case-Control StudyMeasuresMedicalMedicareMethadoneMethodologyNaltrexoneNational Institute of Drug AbuseNested Case-Control StudyOncologyOpiate AddictionOpioidOpioid AnalgesicsOutcomeOverdoseOxycodonePain managementPatientsPatternPersonal SatisfactionPersonsPharmacistsPharmacoepidemiologyPhasePhysiciansPoliciesPolicy MakerPopulationPositioning AttributeProfessional OrganizationsPublic HealthRecommendationReportingReproducibilityResearchRisk FactorsSEER ProgramSocietiesStatutes and LawsStrategic PlanningSubstance Use DisorderSurveysSystemTherapeuticTimeTimeLineTranslationsUnited StatesVeteransVulnerable Populationsbeneficiarycancer paincancer therapycase controlcohortcomorbiditydosageevidence baseexperienceimprovedinterestmedication-assisted treatmentmortalitynational surveillancenon-cancer painopioid abuseopioid epidemicopioid overdoseopioid policyopioid therapyoverdose deathpatient-level barriersprescription opioidprogramsresearch studyresponsesocial health determinantstreatment programtrendtrend analysis
项目摘要
The prescription opioid epidemic, beginning in the late 1990’s saw massive expansion of opioid prescriptions nationwide, ultimately leading professional societies, healthcare systems, and legislative bodies to take measures curbing inappropriate prescription of opioids, particularly at high doses and for chronic use. While some of these have had dramatic and sustained overall effects, there is little known about how trends in opioid prescription, nor opioid-related adverse events and mortality have changed for the cancer survivor population. Moderate to severe cancer pain warranting opioid therapy is very common, and as the cancer survivor population continues to grow, so too does the need to understand how opioid-related policies (even those specifically excluding people with cancer) has affected access to appropriate pain management. This project uses a matched longitudinal cohort methodology in two distinct populations (US veterans and Medicare beneficiaries) in order to longitudinally and quantitatively characterize in people with cancer changes in: opioid prescription rate and dosage, duration of opioid therapy, choices of opioids, opioid-related hospitalizations and emergency department visits, new diagnosis of opioid abuse or dependence, as well as ER visits or hospital admissions for opioid-related adverse events, enrollment in Medication-Assisted Treatment (MAT) programs, and the case fatality rate of opioid overdose events. By studying these events between 2008-2018, we will be able to evaluate the effects of several waves of opioid-related guidelines, policies, and laws at the healthcare system, state, and federal level to see how cancer patients have been affected by the US response to the prescription opioid epidemic. Finally, a second aim of the study will be to use a nested case-control study to specifically analyze opioid overdose events in people with cancer versus those who do not, in order to characterize risk factors for fatal overdoses, including access to prescription opioids. Ultimately, this project has the potential to close several key gaps in the understanding of the prescription opioid epidemic in people with cancer, which could in the immediate term help patients and clinician to better evaluate the risks and benefits of opioid therapy, and in the longer term allow policymakers and professional societies to have a more precise understanding of spillover effects of opioid-related policies on people with cancer.
从20世纪90年代末开始的阿片类药物处方流行病在全国范围内大规模扩大,最终导致专业协会,医疗保健系统和立法机构采取措施遏制阿片类药物的不适当处方,特别是高剂量和长期使用。虽然其中一些具有显著和持续的总体影响,但对阿片类药物处方的趋势以及癌症幸存者人群的阿片类药物相关不良事件和死亡率的变化知之甚少。中度至重度癌症疼痛缓解阿片类药物治疗非常常见,随着癌症幸存者人口的持续增长,了解阿片类药物相关政策(即使是专门排除癌症患者的政策)如何影响获得适当的疼痛管理的必要性也在增加。该项目在两个不同的人群中使用匹配的纵向队列方法(美国退伍军人和医疗保险受益人),以便纵向和定量地描述癌症患者的以下变化:阿片类药物处方率和剂量、阿片类药物治疗的持续时间、阿片类药物的选择、阿片类药物相关住院和急诊就诊、阿片类药物滥用或依赖的新诊断,以及阿片类药物相关不良事件的ER访视或住院,药物辅助治疗(MAT)计划的入组情况以及阿片类药物过量事件的病死率。通过研究2008-2018年期间的这些事件,我们将能够评估医疗保健系统,州和联邦层面的阿片类药物相关指南,政策和法律的几波影响,以了解癌症患者如何受到美国对处方阿片类药物流行病的影响。最后,该研究的第二个目的是使用巢式病例对照研究来专门分析癌症患者与非癌症患者的阿片类药物过量事件,以描述致命过量的风险因素,包括获得处方阿片类药物。最终,该项目有可能弥合对癌症患者处方阿片类药物流行的理解方面的几个关键差距,这可以在短期内帮助患者和临床医生更好地评估阿片类药物治疗的风险和益处,并在长期内使政策制定者和专业协会能够更准确地了解阿片类药物相关政策对癌症患者的溢出效应。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James D Murphy其他文献
Large-scale crowdsourced radiotherapy segmentations across a variety of cancer anatomic sites: Interobserver expert/non-expert and multi-observer composite tumor and normal tissue delineation annotation from a prospective educational challenge
跨各种癌症解剖部位的大规模众包放射治疗分割:来自前瞻性教育挑战的观察者间专家/非专家和多观察者复合肿瘤和正常组织描绘注释
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
K. Wahid;Diana Lin;Onur Sahin;M. Cislo;Benjamin E. Nelms;R. He;M. Naser;Simon Duke;M. Sherer;J. Christodouleas;A. Mohamed;James D Murphy;C. Fuller;Erin F. Gillespie - 通讯作者:
Erin F. Gillespie
Associations Between Radiation Oncologist Demographic Factors and Segmentation Similarity Benchmarks: Insights From a Crowd-Sourced Challenge Using Bayesian Estimation
放射肿瘤学家人口统计因素与细分相似性基准之间的关联:使用贝叶斯估计从众包挑战中获得的见解
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:4.2
- 作者:
K. Wahid;Onur Sahin;Suprateek Kundu;Diana Lin;Anthony Alanis;Salik Tehami;Serageldin Kamel;Simon Duke;M. Sherer;Mathis Rasmussen;S. Korreman;David Fuentes;M. Cislo;Benjamin E. Nelms;J. Christodouleas;James D Murphy;A. S. Mohamed;R. He;M. Naser;Erin F. Gillespie;C. Fuller - 通讯作者:
C. Fuller
James D Murphy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James D Murphy', 18)}}的其他基金
Quantification and Characterization of Opioid Prescription, Overdose, and Fatalities in People with Cancer: A Massive Nationwide, Multi-Cohort Study
癌症患者阿片类药物处方、用药过量和死亡的量化和表征:一项大规模的全国性多队列研究
- 批准号:
10195671 - 财政年份:2021
- 资助金额:
$ 7.9万 - 项目类别:
Distributed knowledge-based platform for radiotherapy plan quality control
分布式放疗计划质量控制知识平台
- 批准号:
10369642 - 财政年份:2018
- 资助金额:
$ 7.9万 - 项目类别:
Interactive Contouring Atlas for Radiation Oncology
放射肿瘤学交互式轮廓图谱
- 批准号:
9182722 - 财政年份:2016
- 资助金额:
$ 7.9万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 7.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 7.9万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 7.9万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 7.9万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 7.9万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 7.9万 - 项目类别:
Discovery Grants Program - Individual